Sulindac inhibited gene expression and activity of arylamine N-acetyltransferase and dna-2-aminofluorene adduct formation in T24 human bladder tumor cells

Urological Research

Volumn 29, Issue 6, 2001, Pages 406-411

  Yang, C ^a   Chung, J ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 aminofluorene; Bladder cancer; DNA adduct; Gene expression; N acetyltransferase; Sulindac

Indexed keywords

2 FLUORENYLAMINE; ARYLAMINE ACETYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; ENZYME ACTIVITY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCUBATION TIME; INHIBITION KINETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR CELL LINE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ARYLAMINE N-ACETYLTRANSFERASE; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; FLUORENES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RNA, MESSENGER; SULINDAC; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0035675380     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-001-0220-7     Document Type: Article

References (32)

1. Arylamine-DNA adducts in vitro and in vivo: Their role in bacterial mutagenesis and urinary bladder carcinogenesis
2. Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression
3. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Sulindac: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases
6. Role of N-acetyltransferase phenotype in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
7. Effects of sulindac on arylamine N-acetyltransferase activity in human colon tumor cells
8. Inhibitory actions of sulindac on growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients
9. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6 J rapid and B6.A-Nats slow acetylator congenic mice
10. Kinetics of arylamine N-acetyltransferase in tissues from human colon tumor
11. Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells
12. The statistical analysis of enzyme kinetic data
13. Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferase
14. Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities
15. N-hydroxyarylamine O-acetyltransferase and its relationship to aromatic amine N-acetyltransferase polymorphism in the inbred hamster and in human tissue cytosol
16. Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver
17. Modulation of genotoxic and cytotoxic effects of aromatic amines in monolayers of rat hepatocytes
18. Acetylator phenotype in colorectal carcinoma
19. Comparison of the polymorphic expression of N-acetyltransferase activity in human colon and bladder cytosol
20. Role of aromatic amines acetyltransferase in human colorectal cancer
21. Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer
22. The effects of sulindac on N-acetyltransferase activity in Pseudomonas aeruginosa
23. N-acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology. Preliminary results in Sweden and Denmark
24. Cloning and expression of cDNA for polymorphic and monomorphic arylamine N-acetyltransferase from human liver
25. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
26. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder
27. Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver
28. Effects of nonsteroidal anti-inflammatory drugs on glutathione S-transferase of the rat digestive tract
29. Sulindac for polyposis of the colon
30. N-acetylation pharmacogenetics
31. Inhibition by vitamin C of DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumor cells